Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Everest Medicines
Biotech
Everest to continue mRNA ascent alone, ending Providence collab
The collaboration between Everest and Providence back in 2021 marked a significant step for the Chinese mRNA sector. Now, Everest is going it alone.
James Waldron
Feb 20, 2024 8:19am
Inventiva, Kezar sell Asian rights to NASH and autoimmune assets
Sep 21, 2023 9:00am
Maxwell Biosciences taps 3 leaders—Chutes & Ladders
Sep 23, 2022 9:30am
Everest appoints Gilead, COVID therapy vet as CEO
Sep 19, 2022 11:58am
Blanchard bolts from Everest, resigning as CEO
Aug 26, 2022 6:14am
Everest inks $561M biobucks deal for renal disease treatment
Sep 17, 2021 10:20am
